2023 Together - IE227 - Margin Shifting: Pharmacy Margin Erosion by For-Profit Companies
During this interactive session, panelists will examine the increasing trend of for-profit companies eroding health systems’ pharmacy-related margins and blocking access to — and shifting savings from — 340B discounted drugs for covered entities. Similar actions by payers and pharmacy benefit managers will also be discussed, along with strategies for preventing and mitigating the impact on your organization.
Target Audience
- Healthcare Quality Professionals
- Nurses
- Pharmacists
- Pharmacy Technicians
- Physicians
- Other Healthcare Professionals
Learning Objectives
- Explain the drivers that are shifting pharmacy-related margins from health systems to for-profit companies.
- Describe strategies to prevent and mitigate margin-shifting actions.
- Discuss broader market trends and forces driving the shifts in sites of care and drug use for 340B hospitals and integrated delivery networks.
Christine Collins, MBA, RPh, Senior Vice President and Chief Pharmacy Officer, Lifespan Rhode Island Hospital, Providence, RI
Kavish Choudhary, PharmD, MS, Chief Pharmacy Officer, University of Utah Hospitals and Clinics, Salt Lake City, Utah
Charlton Park, MBA, MHSM, Chief Financial Officer, University of Utah Hospitals and Clinics, Salt Lake City, UT
Chris Hatwig, MS, RPh, President, Apexus (Moderator)
Credit Types
Interprofessional Continuing Education (IPCE)
This activity was planned by, and for, the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credits for learning and change.
Available Credit
- 0.75 ACPE Pharmacist
- 0.75 ACPE Pharmacy Technician
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 CPHQ – Certified Professional Healthcare Quality
- 0.75 General CE - Attendance
- 0.75 Interprofessional Continuing Education (IPCE)